Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Review cancelled for J&J schizophrenia drug
Paliperidone, a new chemical entity, is the first and only atypical antipsychotic to use the OROS extended release technology. This technology provides a continuous release of medication over
Paliperidone, a new chemical entity, is the first and only atypical antipsychotic to use the OROS extended release technology. This technology provides a continuous release of medication over
If approved the product will be the first and only ADHD stimulant product that controls inattention, hyperactivity and impulsivity for up to 16 hours. The application is subject
Arxxant (ruboxistaurin mesylate) is an investigational oral drug for the treatment of moderate to severe non-proliferative diabetic retinopathy, a diabetic eye disease. The co-promotion agreement is subject to
Advanced Influenza Technologies (AIT) holds the license for a DNA-based Influenza vaccine candidate developed at the University of Massachusetts Medical School. “Years of effort have been expended developing
The contract will run for a period of two years with an initial contract award amount of $16.8 million. Under the contract, 59 jurisdictions will be able to
Hereditary angioedema (HAE) is a human genetic disorder caused by a shortage of C1 inhibitor activity. The disease is characterized by acute attacks of painful swelling of soft
General practitioners often prescribe antibiotics for respiratory tract infections when nasal discharge is purulent. Most guidelines recommend against their use for this condition, but this advice is based
Biocon Biopharmaceuticals, a joint venture between Biocon and Cimab SA, has rights to the drug from Cimab for the Indian subcontinent. In other markets, including Europe, North America,
Under the terms of the agreement, Beijing Med-Pharm will serve as the exclusive distributor of Anpo (ritodrine hydrochloride), a treatment for preterm labor, in mainland China. Beijing Med-Pharm
The Generic Pharmaceutical Association (GPhA) said the measure will close another loophole that needlessly delays generic entry into the market. The association claims this tactic has been used